Bespoke ashwagandha supplement manufacturing

Root-only ashwagandha, from powder to standardised extract

Private label ashwagandha supplements for brands, and bespoke formulas built around ashwagandha, go from formula to finished pack in-house in Leicester. We make capsules, tablets, gummies, powders and drink mixes, calm and focus pouches, and drops and shots, with the daily dose set inside the range human trials used, usually 300 to 600 mg of standardised root extract. Every lot is held until HPTLC confirms the root and HPLC confirms its withanolide content. Every batch comes with a certificate of analysis and a batch release confirmation.

Ashwagandha (Withania somnifera) root extract is a staple of stress, calm and sleep ranges. It ranked third among herbal supplements in US mainstream retail in 2024, with sales up 13.8%, according to the American Botanical Council's Herb Market Report, as reported by NutraIngredients (September 2025). Ashwagandha sits within our sleep, stress and mood supplement manufacturing.

As of October 2026, ashwagandha can be sold in food supplements in the UK, no EU-wide rule restricts it, and it sells as a dietary supplement ingredient in the US; Denmark does not allow products containing it. We design every formula to the rules of the markets you sell in, from the plant part on the specification to the cautions on the label.

Most commercial ashwagandha supplements contain extracts of the root, and the chemistry of the root differs from that of the leaf (NIH Office of Dietary Supplements, 2025). We work only with the root. Your formula is yours, and its specification fixes the plant part, extraction solvent and withanolide content before the first batch.

Withanolides are steroidal lactones, and suppliers declare them in different ways: as total withanolides, as withanolide glycosides, or as milligrams per capsule (NIH Office of Dietary Supplements, 2025). These figures do not convert one to one, so the specification fixes the method with the value.

300 to 600 mg of ashwagandha root extract, with label cautions

The trial range and three months of use

Human trials reviewed by the NIH Office of Dietary Supplements used 240 to 1,250 mg of extract a day in studies of stress, with effects that appeared greater at 500 to 600 mg a day than at lower doses, and 250 to 600 mg a day of root extract in studies of sleep (2025). The same review says ashwagandha appears to be well tolerated for up to about three months of use, but its long-term safety is not known. We set the daily dose inside the trial range, usually 300 to 600 mg of standardised root extract, and agree any wording on duration of use with you.

Absorption and delivery

Withanolides occur as aglycones and as glycosides, whose sugar groups make them more soluble in water. No authorised claim depends on enhanced absorption, so we build on the extract types and doses that human trials used, and add delivery systems such as liposomes only where human data support them.

Interactions and label cautions

Ashwagandha might interact with medicines including thyroid hormone medicines, immunosuppressants and sedatives, according to the NIH Office of Dietary Supplements (2025), and Germany's BfR advises that children and pregnant and breastfeeding women should not take ashwagandha food supplements (BfR, 2024). We draft label cautions for each target market from these positions and update them when a regulator acts.

A bitter, earthy extract that takes up moisture

Root extract tastes bitter and earthy. Our flavour development and taste masking sets the flavour system with the dose, not after it. Dry botanical extracts take up moisture, so we set humidity limits for production, choose barrier packs and confirm withanolide content in the final pack through stability studies on every new formula.

Ashwagandha's legal status, country by country

As of October 2026, the panel on this page sets out where ashwagandha can be sold. Our supplement regulation watch reviews every line each quarter, and we tell clients when a change affects their product.

UK food supplements only, under review

Ashwagandha can go into food supplements in the UK, and other foods need a novel food authorisation first, so every UK ashwagandha product we make is a food supplement, whatever its format. Its safety is under review in the UK, so every ashwagandha formula we develop has a ready alternative.

EU rules country by country

No EU-wide rule restricts ashwagandha in food supplements, and each member state's rules for botanicals apply. We check every target country before formulation and flag any market that bars the plant, such as Denmark, before the specification is fixed.

Claims in Great Britain and the EU

Ashwagandha has no authorised health claim, and botanical claims remain on hold, so GB and EU labels carry nutrient claims instead, such as "Magnesium contributes to normal psychological function" or "Vitamin B6 contributes to normal psychological function", each for a product that is at least a source of the nutrient. We check every claim and caution against the rules of each market at artwork stage, before anything is printed.

US labels naming the root

Ashwagandha sells as a dietary supplement ingredient. Structure and function claims, such as "supports relaxation", need competent and reliable scientific evidence, a notification to FDA and FDA's disclaimer, and a claim to replace a medicine makes the product a drug. Every US label carries a Supplement Facts panel naming the root as the plant part.

Private label ashwagandha in capsules, gummies, drinks and pouches

• Capsules: a daily dose of 300 to 600 mg of standardised root extract fits in one or two capsules, according to the extract's density; see capsule and tablet manufacturing.
• Tablets: suit combination formulas, such as ashwagandha with magnesium and vitamin B6, where the dose of each active sets the tablet size.
• Gummies: carry part of the daily dose, with the bitterness masked, and every gummy batch gets an active assay as standard; see gummy manufacturing.
• Powders and drink mixes: root powder or extract in evening drinks and lattes, alongside magnesium; see powder supplement manufacturing.
• Pouches and liquids: calm and focus pouches pair ashwagandha with L-theanine, and drops and shots carry the extract in a liquid base.

Capsules, gummies, pouches and liquids sit inside our BSI HACCP and GMP scope, so they are GMP certified, and tablets and powders are made in the same Leicester facility. We are ISO 9001, HACCP and GMP certified by BSI, and FDA registered. Mood formulas can pair ashwagandha with saffron; evening formulas leave out melatonin, a prescription-only medicine in the UK.

We choose the format with you at concept stage, from the daily dose, the taste and the markets on your plan. Each active in a combination formula gets its own specification, and the blend is checked for uniformity, so every nutrient that carries a claim is present at its declared level in every serving.

Every ashwagandha root lot held until HPTLC and HPLC pass

1. Specify. We fix the plant part, solvent, withanolide content and test method with you, and set the dose, cautions and claims for each market.
2. Source. The extract comes from a supplier that has passed our supplier approval, reviewed annually, with a certificate of analysis for every lot.
3. Verify on receipt. Each lot is held until it passes its specification, including identity by HPTLC against an authenticated root reference and a withanolide assay by HPLC.
4. Weigh and blend. Materials are weighed against the batch record under our allergen management plan, with yellow colour coding, then blended and checked for uniformity.
5. Fill or form. Capsules are filled and checked by weight, tablets compressed, powders filled or sealed into stick packs, gummies cooked, deposited and set, and pouches filled and sealed.
6. Pack. Each product goes into the pack its stability study approved: bottles with a desiccant for capsules and tablets, foil stick packs for single servings, and lined pouches or tubs for drink mixes, each coded with its batch number and best-before date.
7. Label and release. Label verification on every batch is the critical control point in our HACCP plan, and quality control releases every batch against its specification.

Proving the root and its withanolides, batch after batch

Every batch is tested by accredited partner laboratories (ISO/IEC 17025), and batch testing is part of every order. For ashwagandha, the panel covers:

• Identity: an HPTLC fingerprint, the identification procedure for botanicals in the European Pharmacopoeia and the United States Pharmacopeia, run against an authenticated root reference to confirm the plant and the plant part.
• Withanolide assay: by HPLC, at release and across shelf life, using the method named in the specification.
• Contaminants: lead, cadmium and mercury by ICP-MS against the EU limits for food supplements, pesticide residues, residual solvents where the extract uses them, and microbiology.
• Stability: withanolide content, moisture and taste tracked in the final pack.

Our quality system adds a HACCP study per product type, reviewed annually; three retained samples per batch, kept for shelf life plus one year; and a full mock recall, forward and backward with mass balance, in seconds. Nothing is dispatched without quality control sign-off. Our testing and batch release page sets out each method.

Every batch comes with a certificate of analysis and a batch release confirmation. Development adds the documents your brand keeps: the formula, the specification, the stability data and a claims and label review for each market.

Every project runs through the same development stages: brief, evidence review, formulation, bench samples, blind sensory panels to settle the bitterness, a pilot batch on production equipment, stability in the final pack, and scale-up into routine production. Each stage leaves a record you keep.

Research and development is a paid stage that can be included with an order of the right size. Start your project with your target markets, and we will propose the extract, dose and claims route.

References: NIH Office of Dietary Supplements, ashwagandha fact sheet for health professionals (2025); BfR, Communication 39/2024 on ashwagandha food supplements (2024); Food Standards Agency, call for evidence on ashwagandha (2024); Regulation (EC) No 1925/2006 on the addition of vitamins, minerals and certain other substances to foods (2006); Regulation (EU) No 432/2012 (2012); United States Pharmacopeia, General Chapter <203> (2019).